United States Preventive Vaccine Market Poised for Strong Growth Amid Rising Immunization Demand and Breakthrough Innovations 2025 | Top key players - AstraZeneca, Astellas Pharma Inc., Pfizer, Inc.

Market Overview:

The Preventive Vaccine Market is expected to grow at a CAGR of 5.3% during the forecast period 2024-2031.

The Preventive Vaccine Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market participants to capitalize on these opportunities. Overall, the Preventive Vaccine market report is an essential resource for market participants who are looking to gain a comprehensive understanding of the market and identify opportunities for growth.

Download a Free sample PDF (Use Corporate email ID to Get Higher Priority) at: https://datamintelligence.com/download-sample/preventive-vaccine-market?sz

The Preventive Vaccine Market refers to the global industry focused on developing, producing, and distributing vaccines that protect individuals from infectious diseases before exposure. It encompasses a wide range of vaccines targeting viral, bacterial, and emerging pathogens. Growth is driven by rising immunization programs, government initiatives, technological advancements, and increasing awareness of disease prevention and public health.

Recent Key Developments of United States (U.S):

COVID-19 Vaccine Approvals and Restrictions (August 2025): The FDA approved updated COVID-19 shots from Pfizer, Moderna, and Novavax. However, they limited their use for younger adults and children to those with a high-risk health condition. The new shots are approved for all seniors. The FDA also revoked the emergency authorization for Pfizer's vaccine for children under 5.

Meningococcal Vaccine Recommendation (June 2025): The Advisory Committee on Immunization Practices (ACIP) recommended GSK's MenABCWY vaccine for use when both MenACWY and MenB vaccines are indicated at the same visit for certain populations, including healthy adolescents and individuals at increased risk for meningococcal disease.

RSV Vaccine Recommendations (June-August 2025): The ACIP recommended a single dose of RSV vaccine for adults aged 50-59 who are at an increased risk of severe RSV disease. Additionally, a recommendation was adopted for infants under 8 months who are born during or entering their first RSV season to receive one dose of either nirsevimab or clesrovimab if not protected by maternal vaccination.

Chikungunya Vaccine Recommendation (May 2025): The ACIP recommended a chikungunya vaccine for individuals aged 12 and older traveling to or residing in areas with an outbreak. The vaccine was also recommended for laboratory workers with potential exposure to the virus.

Politicization of Public Health and State-Level Action (September 2025): A split in public health guidance has emerged. Following changes to the CDC's Advisory Committee on Immunization Practices (ACIP), which led to a lack of recommendation for new COVID-19 shots for healthy children, a group of West Coast states (California, Oregon, Washington, and Hawaii) formed an alliance and issued their own unified, science-based vaccine recommendations for the 2025-2026 season. California also passed a law to base future immunization guidance on independent medical organizations rather than the CDC.

Key Players:

AstraZeneca
Astellas Pharma, Inc.
Pfizer, Inc
Johnson & Johnson
GSK plc
Merck & Co., Inc.
Sanofi
Bavarian Nordic
Emergent Biosolutions
Mitsubishi Tanabe Pharma Corporation.

This Report Covers:

✔ Go-to-market Strategy.

✔ Neutral perspective on the market performance.

✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.

✔Customized regional/country reports as per request and country level analysis.

✔ Potential & niche segments and regions exhibiting promising growth covered.

✔ Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=preventive-vaccine-market

Market Segmentation:

By Vaccine Type: Live Attenuated Vaccines, Inactivated Vaccines, Subunit, recombinant, conjugate, and polysaccharide vaccines, mRNA vaccines, Toxoid Vaccines, Viral vector vaccines.

By Route of Administration: Oral, Subcutaneous, Others.

By Disease Indication: Pneumococcal Disease, Varicella, Human Papilloma Virus, Influenza, Meningococcal Disease, MMR (Measles, Mumps, Rubella), Polio, Hepatitis, Dengue, DPT (diphtheria, pertussis, and tetanus), Rotavirus, Yellow Fever, Typhoid Fever, Others.

By End-User: Adults, Pediatrics.

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/preventive-vaccine-market?sz

Chapter Outline

⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Preventive Vaccine market segments, study objectives, and years considered.

⏩ Market Landscape: The competition in the Global Preventive Vaccine Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.

⏩ Companies Profiles: The global Preventive Vaccine market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.

⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Preventive Vaccine Market.

⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

People Also Ask:

◆ How big is the Preventive Vaccine Market in 2025?
◆ What is the projected growth rate of the Preventive Vaccine Market through 2033?
◆ Who are the key players in the Preventive Vaccine Market?
◆ Which region is expected to dominate the industry during the forecast period?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.